Clinical Trial Update: The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating whether MICARDIS (telmisartan) improves insulin sensitivity in overweight/obese non-diabetic, normotensive adults; the trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Obesity, Insulin Resistance | Phase 2 | Status: COMPLETED